Literature DB >> 24307282

Tumor-suppressing effects of miR-141 in human osteosarcoma.

Haidong Xu1, Qiang Mei, Chengjie Xiong, Jianning Zhao.   

Abstract

Osteosarcoma is the most common primary malignancy to arise from bone. The pathogenesis of osteosarcoma is unclear, and new therapy molecular target is needed. The miRNAs researched suggested that miRNAs are involved in the pathogenesis of osteosarcoma. MiR-141, which belong to miR-200 family, take a part in tumorigenesis. However, the role of miR-141 in the pathogenesis of osteosarcoma remained unclear. In this study, we focused on the miR-141 in osteosarcoma and found that the expression of miR-141 is lower in osteosarcoma. Overexpression of miR-141 not only inhibits osteosarcoma cell proliferation but also induces cell apoptosis. It is estimated that miR-141 played its role via ZEB1 and ZEB2. In all, miR-141 played a osteosarcoma-suppressing role via ZEB1 and ZEB2. Our finding may elucidate the miRNAs mechanism in osteosarcoma and provide a new molecule target for osteosarcoma therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24307282     DOI: 10.1007/s12013-013-9801-7

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  18 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.

Authors:  Peiheng He; Ziji Zhang; Guangxin Huang; Hua Wang; Dongliang Xu; Weiming Liao; Yan Kang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

3.  Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Authors:  Takeshi Chiyomaru; Shinichiro Fukuhara; Sharanjot Saini; Shahana Majid; Guoren Deng; Varahram Shahryari; Inik Chang; Yuichiro Tanaka; Hideki Enokida; Masayuki Nakagawa; Rajvir Dahiya; Soichiro Yamamura
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

4.  miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.

Authors:  Haidong Xu; Xiaozhou Liu; Juan Zhou; Xiaoyun Chen; Jianning Zhao
Journal:  Oncol Lett       Date:  2016-11-07       Impact factor: 2.967

5.  A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.

Authors:  Branden S Moriarity; George M Otto; Eric P Rahrmann; Susan K Rathe; Natalie K Wolf; Madison T Weg; Luke A Manlove; Rebecca S LaRue; Nuri A Temiz; Sam D Molyneux; Kwangmin Choi; Kevin J Holly; Aaron L Sarver; Milcah C Scott; Colleen L Forster; Jaime F Modiano; Chand Khanna; Stephen M Hewitt; Rama Khokha; Yi Yang; Richard Gorlick; Michael A Dyer; David A Largaespada
Journal:  Nat Genet       Date:  2015-05-11       Impact factor: 38.330

Review 6.  Role of MicroRNA-141 in the Aging Musculoskeletal System: A Current Overview.

Authors:  Babatunde Fariyike; Quante Singleton; Monte Hunter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Mech Ageing Dev       Date:  2018-12-07       Impact factor: 5.432

7.  MicroRNA‑141 inhibits the differentiation of bone marrow‑derived mesenchymal stem cells in steroid‑induced osteonecrosis via E2F3.

Authors:  Fei Xue; Jian Wu; Wei Feng; Ting Hao; Yuan Liu; Wenbo Wang
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

8.  A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study.

Authors:  Hala M Hatab; Fatma F Abdel Hamid; Ahmed F Soliman; Tamer A Al-Shafie; Yahia M Ismail; Motawa E El-Houseini
Journal:  J Gastrointest Oncol       Date:  2019-08

9.  MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2.

Authors:  Dan Fei; Kunchi Zhao; Hongping Yuan; Jie Xing; Dongxu Zhao
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

10.  MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.

Authors:  Yusheng Li; Chao Zeng; Min Tu; Wei Jiang; Zixun Dai; Yuling Hu; Zhenhan Deng; Wenfeng Xiao
Journal:  Onco Targets Ther       Date:  2016-05-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.